SGRY vs PACS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 10, 2026

SGRY

39.2
AI Score
VS
SGRY Wins

PACS

38.0
AI Score

Investment Advisor Scores

SGRY

39score
Recommendation
EXTENDED

PACS

38score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric SGRY PACS Winner
Forward P/E 588.2353 18.7617 PACS
PEG Ratio 1.66 1.2502 PACS
Revenue Growth 2.7% 11.5% PACS
Earnings Growth 0.0% 15.6% PACS
Tradestie Score 39.2/100 38.0/100 SGRY
Profit Margin -2.6% 4.9% PACS
Beta 1.00 1.00 Tie
AI Recommendation EXTENDED AVOID NEW MONEY SGRY

Relative Price Performance (Last 90 Days)

SGRY 1M: +83.2% · 3M: +75.5% PACS 1M: +12.8% · 3M: +11.3%

Current Technical Phase

SGRY

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (17.9% over 20 days), RSI 90

RSI (14): 90.1 · Price: $26.66

PACS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.2% over 20 days), RSI 60

RSI (14): 60.5 · Price: $50.06

Fundamentals Snapshot

Metric SGRY PACS
Market Cap — —
Forward P/E 171.8 17.6
Trailing P/E — 27.7
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 0.2% 0.2%
Operating Margin 0.1% 0.1%
EPS -0.67 1.77
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, SGRY is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.